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Various mononuclear phagocyte populations differ considerably in their capacity 
to produce and secrete plasminogen activators (PA) 1 in vitro. For example, resident 
peritoneal macrophages show very little PA activity, whereas, thioglycollate medium- 
induced peritoneal exudate macrophages secrete high levels of this enzyme (1). It has 
been  shown that  the  majority of exudate  macrophages are  freshly recruited  blood 
monocytes (2-4) and there is evidence that recent arrivals are the cells that secrete PA 
(5). 
Large numbers  of mononuclear phagocytes can be obtained when bone marrow 
cells  are grown in  liquid  culture  in  the  presence of a  growth factor, called  colony- 
stimulating  factor  (CSF)  (6-9).  They are  presumably derived  from the committed 
hemopoietic stem cells for both granulocytes and monocytes-macrophages (CFU-C) 
(10,  11). Recent studies have shown that these adherent mononuclear phagocytes can 
be rendered cytotoxic in vitro and they can also serve as indicator cells  for migration 
inhibitory factor (8, 9). 
In  this study,  we  investigated  PA secretion  by mononuclear phagocytes derived 
from bone marrow cells in culture and also the factors which modulate the secretion 
of PA by these cells,  particularly the role of CSF. 
Materials and Methods 
Animals.  Swiss  mice of both sexes,  bred  in  this Department  and weighing 25-30  g,  were 
used in all studies. 
Media.  a-Minimal essential medium 0x-MEM) (Flow Laboratories,  Irvine, Scotland) with- 
out nucleosides was used for growing bone marrow cells and mouse L cells. Dulbecco's MEM 
was used during the incubation of cells for PA secretion. 
Preparation of Gelatin-Coated Flasks.  Gelatin solution (0.1% wt/vol in glass-distilled water) was 
prepared and sterilized by autoclave. After cooling to -~50°C, 3 ml of this solution was pipetted 
into each flask (Falcon, 24 cm  2, Falcon  Labware,  Div. of Becton, Dickinson, & Co., Oxnard, 
Calif.). These  flasks were left at 4°C with  the side to be coated down. After 2 h, the excess 
gelatin solution was removed by suction. The flasks were then dried at 37°C for 2 d with their 
caps loosened. Gelatin-coated  flasks were stored at room temperature. 
* Reprint requests, Section of Cancer Biology,  Division of Radiation Ontology, Mallinckrodt Institute 
of Radiology, Washington University, School of Medicine, St. Louis, Missouri. 
i Abbreviations used in  this paper: ATDS, acid-treated dog serum; BMDM, bone marrow-derived mono- 
nuclear phagocytes; CFC, colony-forming cells;  CFU-C,  the committed stem cells  for both granulocytes 
and macrophages; Con  A-SCM, medium conditioned by concanavalin A-stimulated spleen cells;  CSF, 
colony-stimulating faztor;  FCS,  fetal  calf serum;  LCM,  L-cell-conditioned  medium;  MEM,  minimal 
essential medium; PA, plasminogen activator; PBS, phosphate-buffered saline; RPM, resident peritoneal 
macrophages; TPM, thioglycollate medium-induced peritoneal macrophages. 
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Bone Marrow  Cell Culture.  Cells from femoral bone marrow  were obtained  by flushing the 
femur with a  23-gau~e needle attached to a  2-ml syringe containing a-MEM. To each gelatin- 
coated flask,  1  ×  10  bone marrow cells in 5 ml of growth  medium were added.  The growth 
medium contained a-MEM supplemented with 10% fetal calf serum (FCS) (Flow Laboratories), 
5% horse serum, 10% L-cell-conditioned medium (LCM) and 2 mM glutamine. It also contained 
100 U/ml penicillin, i00 #g/ml streptomycin, and  100/~g/ml kanamycin. These cultures were 
flushed with 5% CO2 in air before the caps were tightened. They were kept at 37°C and the 
cells  were  harvested  at  various  times  as  described  later.  Adherent  cells  were  detached  by 
incubation for 5-10 min in lidocaine solution (15 mM in Dulbeeco's MEM supplemented with 
10%  FCS)  and  washed  twice with  Dulbecco's MEM  before use  (12).  Bone  marrow  cultures 
were also prepared in bags of teflon FEP fluorocarbon film (13)  (type 100A, Du Pont, Richard 
Klinger Ltd., Sidcup, Kent) or in Petriperm dishes (Heraeus, TR International Chemicals Ltd., 
London)  for comparison with gelatin-coated flasks. 
Peritoneal Cells.  Resident  peritoneal cells were washed out with Ca  2+ and Mg2+-free phos- 
phate-buffered saline  (PBS) from normal unstimulated  mice. Thioglycollate medium-induced 
exudate cells were obtained 4 d after an intra~eritoneal injection of 1 ml Brewer's thioglycollate 
medium. These cells were plated,  3-5  ×  10  cells per gelatin-coated  flask,  in 5  ml of growth 
medium.  24 h  later, the nonadherent  cells were removed by washing the flasks twice with a- 
MEM and the adherent cells harvested with lidocaine solution. 
Blood Mononuclear Cells.  Blood was  obtained  from  mice by cardiac puncture.  Acid citrate 
dextrose solution was used as anticoagulant  and blood mononuclear cells were obtained by a 
Ficoll-Hypaque technique  described  by  Boyum  (14).  Between  3  and  6%  of the cells in  this 
fraction could be identified morphologically as monocytes. 
Pulmonary Alveolar Cells.  After mice  were  killed,  a  sterile polyethylene  tube  was  inserted 
through the trachea and the lungs lavaged with Ca  2+- and MgZ+-free PBS (15).  About 3  ×  105 
cells were obtained from a single mouse, of which >95% were alveolar macrophages. 
Preparation of LCM.  Mouse L  cells (strain  929)  were seeded in  75-cm  2 tissue culture  flasks 
(Falcon  Labware,  Div. of Becton,  Dickinson,  &  Co.)  at  1  ×  106  cells in  20  ml  of a-MEM 
supplemented with 10% FCS. 7 d later, the medium was harvested and filtered through a 0.22- 
micron  Millipore  filter  (Millipore  Corp.,  Bedford,  Mass.)  to  insure  a  cell-free conditioned 
medium. Conditioned medium was stored frozen until use. For serum-free LCM, L cells were 
grown for 4 d. The medium was then removed and the flask washed twice with a-MEM. 20 ml 
ofa-MEM was added and the cultures were incubated at 37°C for 3 more d before the medium 
was harvested. 
Preparation of Conditioned Medium from  Concanavalin A-Stimulated  Spleen Cells. Spleens  were 
removed from mice and cell suspensions prepared. The method described by Vassalli and Reich 
(16)  was used to obtain conditioned medium from concanavalin A  (Con A)-stimulated spleen 
cells. The cells suspended  in  Dulbecco's MEM  supplemented  with  5%  heat-inactivated  FCS 
were cultured at 37°C for 20 h  in Falcon  100-mm tissue culture Petri dishes at a  density of 6 
×  106 cells/ml,  10 ml per dish,  in the presence or absence of 4 #g/ml Con A. The cells were 
washed twice and resuspended in Dulbecco's MEM at a density of 6  ×  106 cells/ml. They were 
replated in new Petri dishes at 6  ×  107 cells per dish and incubated at 37°C in CO2 incubator. 
Medium was collected 24 h  later, centrifuged for 15 min at 500 g to remove cells and stored at 
-20°C until use. In comparison to LCM, these conditioned media contained very little colony 
stimulating activity (<1/100 by volume). 
CSF.  Highly purified CSF, obtained  from Dr.  D. M. Chen of Washington  University, St. 
Louis, was prepared from serum-free LCM according to the method of Stanley and Heard (17). 
Assay for Colony-Forming Cells.  The number of mononuclear phagocyte colony-forming cells 
was  determined  by a  previously described  method  (15,  18,  19).  Cells were mixed with  agar 
medium containing  10% fetal calf serum, 5% horse serum,  10% LCM, and 0.3% Bacto agar in 
a-MEM.  1 ml of this mixture was plated  in 35-mm  Falcon culture dishes.  These dishes were 
incubated in a 37°C incubator continuously flushed with 5% CO2 in air. Cells were also grown 
in  1 ml of liquid medium  which contained  the same ingredients  as the agar medium except 
agar. 
Assay  of Fibrinolytic Activity.  Fibrinolysis  was  assayed  on  x25I-fibrin-coated  Linbro  plates 
(Linbro Chemical Co., Hamden,  Conn.),  prepared  as described  (20).  To measure  fibrinolysis 
by intact cells, adherent  cells were detached  from gelatin-coated flasks with lidocaine solution HSIU-SAN  LIN AND SAIMON GORDON  233 
and washed twice with Dulbecco's MEM without serum.  Different cell concentrations, 2  X 
104-2  ×  105  in  0.5-1  ml  of Duibecco's MEM,  were  added  to  a2~I-fibrin-coated wells and 
incubated for 30-60 rain at 37°C in the presence of 5% CO2 to adhere. 25-50/LI of acid-treated 
dog serum (ATDS, pH 2 for 30 rain at room temperature) were then added to each well as a 
source of plasminogen, final concentration 5% vol/vol. The cultures were incubated at 37°C in 
the presence of 5% CO2.  100-/~1 samples of medium were withdrawn at 2.5 and 4 h  after the 
addition of ATDS to assay for release of radioactivity in a  Packard gamma counter (Packard 
Instrument Co., Inc., Downer's Grove, Ill.). Assays were performed in duplicate and appropriate 
controls  included  in  all  experiments.  This  procedure  was  modified, as  described later,  to 
measure the effect of various test solutions on fibrinolysis by cells. 
For  cell-free assays  of fibrinolysis, serum-free  conditioned  media  and  cell  lysates  were 
prepared as described elsewhere (20). Bone marrow-derived mononuclear phagocytes (BMDM) 
were cultivated for 6  d  and  thioglycollate medium-induced peritoneal macrophages  (TPM) 
and resident peritoneal macrophages (RPM) for 1 d, in a-MEM with 10% FCS and 10% LCM. 
The adherent cells were washed three times and fed 3 ml Dulbecco's MEM supplemented with 
0.1%  wt/vol  lactalbumin hydrolysate for  2  d  before collecting conditioned media and  cell 
lysates. Samples  (10-50 ILl) were assayed on  125I-fibrin  in  400  ~1  0.1  M  Tris  HC1,  pH  8.1, 
containing  100  p.g  bovine  serum  albumin,  in  the  presence  or  absence  of  10  /~g  human 
plasminogen which  had  been  purified by lysine sepharose chromatography  (20).  A  unit  of 
fibrinolytic activity was defined as the solubilization of 10% of the total radioactivity releasable 
by trypsin, per 4 h, at 37°C. 
Agarose-Overlay Assay for the Detection of Plasrninogen Activator Production.  For the detection of 
PA secretion by individual colonies, we used a  method adapted from that of Goldberg (21). 
The overlay mixture consisted of 0.5%  agarose,  1.33% nonfat  dry milk, Dulbecco's medium, 
and 5% ATDS. Flasks with discrete colonies were washed twice with warm PBS and the agarose 
overlay added. The overlay was allowed to harden at room temperature for 5 min and then 
incubated at 37°C for 4-12 h. 
Protein Assay.  Protein was assayed using the method of Lowry et al. (22). 
Materials.  Gelatin was obtained from Oxoid, Ltd., London; bactoagar from Difco Labora- 
tories, Detroit, Mich.; agarose from BDH, Poole, Dorset; dog serum from Gibco-Biocult, Paisley, 
Scotland. 
Results 
Bone Marrow Cell Culture.  The replication of bone marrow cells in growth medium 
began within  1 d, first as small clusters of nonadherent  cells and yielding aggregates 
of  8-32  adherent  cells  by  day  3.  The  continuous  clonal  growth  of  these  cells, 
presumably derived from CFU-C, resulted in fusion of the colonies and formation of 
a  confluent  monolayer of adherent  cells between  days 6  and  8.  After day 8,  some 
adherent cells became detached unless the cultures were refed with complete growth 
medium. Both granulocyte and mononuclear phagocyte colonies were present during 
the  early  stage  of  culture.  However,  after  day  5,  >98%  of  adherent  cells  were 
mononuclear phagocytes. We routinely used adherent cells from 6- to 8-d-old cultures 
as the source BMDM. When LCM was omitted, there was no appreciable proliferation 
of bone marrow cell suspensions plated at  1  ×  106 cells per flask. 
We did not  notice any difference in  the growth  of bone  marrow  cells in  gelatin- 
coated and standard uncoated tissue culture flasks. However, the use of gelatin-coated 
flasks facilitated the recovery of viable adherent  cells from the flasks after treatment 
with lidocaine. We recovered 85-99% of adherent cells, of which 80-95% were viable 
by  trypan  blue  dye exclusion.  In  contrast,  only  70-80%  of adherent  cells could  be 
recovered from uncoated flasks, of which 65-80% were viable. This was also true for 
peritoneal macrophages.  Bone marrow  cultures in Teflon-film bags or in  Petriperm 
dishes  yielded more  loosely adherent  mononuclear  phagocytes  which  could  be  de- 234  PLASMINOGEN  ACTIVATOR  IN  BONE  MARROW  MACROPHAGE 
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Fro.  1.  Fibrinolysis by BMDM,  TPM,  and RPM. To each ~2%fibrin-coated well, 5  x  10  4 BMDM 
orTPMor  1  x  10  6RPMwereadded. 
tached  by vigorous pipetting without  the  use of lidocaine.  Experiments done  with 
such  BMDM  gave similar results  to  those with  cells prepared  routinely  in  gelatin- 
coated flasks. 
Fibrinolytic Activity  of BMDM.  BMDM  obtained  from bone marrow after  7 d  in 
culture  were tested  for fibrinolytic activity as described  earlier and  compared with 
RPM and TPM which had been cultured in gelatin-coated flasks in the same growth 
medium  for  one  day.  As  shown  in  Fig.  1,  the  BMDM  displayed  a  high  level  of 
fibrinolytic activity, similar to that of TPM, whereas fibrinolysis by resident  macro- 
phages was very low. Fibrinolysis by BMDM was proportional to cell number and, in 
eight  separate  experiments,  was  consistently  at  least  20-fold  greater  than  that  of 
resident  peritoneal macrophages. The activity per cell was equal  to or only slightly 
less  than  that  of TPM.  The data  on resident  and  exudate peritoneal  macrophages 
were in good accord with a  previous report (1). 
Conditioned  medium  and  cell  lysates  prepared  from similar  cultures  were  next 
examined to define the fibrinolytic activity of BMDM. Table  1 shows that the high 
level of fibrinolysis in cultures  of BMDM  and TPM  was strictly dependent  on the 
presence of plasminogen and was found almost entirely in the conditioned  medium 
fractions, confirming that BMDM secreted plasminogen activator as actively as TPM. 
The intracellular level of PA was somewhat lower in BMDM than in TPM, possibly 
as a result of the presence of inhibitors of fibrinolysis. Resident macrophages secreted 
only low levels of PA and inhibition  of fibrinolysis could be detected  in both intra- 
and extracellular fractions. 
Relationship  between Fibrinolytic Activity  and  Colony-forming Cells.  TPM  and  RPM 
differ in proliferative activity as well as in production of plasminogen activator. TPM 
contain  between  5  and  20%  of cells  that  are  able  to  proliferate extensively in  the 
presence of CSF  and  form colonies  in  vitro  (PE-CFC),  whereas  <0.1%  of resident 
macrophages  are  colony-forming  cells  (18).  Because  fibrinolysis  by  BMDM  was 
comparable  to  that  of  TPM,  it  was  of  interest  to  compare  the  colony-forming 
capacities of BMDM and TPM. HSIU-SAN LIN AND SALMON GORDON  235 
TABLE  I 
Fibrinolysis by Different Macrophages 
Fibrinolytic  activity 
Cells  Conditioned  medium  Cell lysate 
Pig indep.*  Pig dep.:]:  Pig indep.  Pig dep. 
Cell protein 
per culture 
U/mgpmte&  mg 
RPM  -6.5  +4.4  -3.9  -0.5  1.0 
BMDM  0  +78  -5.3  +4.5  0.66 
TPM  0  +84  0  +17  1.6 
* Pig indep., plasminogen independent. 
:]: Pig dep., plasminogen dependent. 
TAnLE  II 
CFC and Fibrinolytic Activity of Various Mononuclear Phagocyte Populations 
Incidence of CFC per 10  a cells 
Cells  Fibrinolytic 
Liquid  Agar  activity* 
BMDM  112 +  24~  101  +  28  32 
RPM  < 1  <0.1  3 
TPM  62 ±  18  77  +  20  38 
Blood mononuclear cells  46 ±  5  2 ±  1  1 
Alveolar macrophages  114 ±  29  120 ±  3~  21 
* Radioactivity released (percentage of total) in 2.5 h. The wells contained either 1 ×  105 
BMDM, TPM, or alveolar macrophages, or 1 ×  106 RPM or blood mononuclear cells. 
Mean --- SEM. 
When  7-d BMDM  cultures were cloned in liquid and agar, we observed a  class of 
colony-forming  cell  with  growth  kinetics  intermediate  between  those  of  the  fast 
growing CFU-C and slow growing peritoneal exudate colony-forming cells. Replica- 
tion began within 2-3 d  and aggregates of>50 cells had formed after 7-10 d  in liquid 
culture or somewhat more slowly in agar, with colonies containing 100-200 cells after 
10  d.  Equal  numbers  of colonies were  formed  in  liquid  and  agar cultures  and  the 
incidence of colony-forming cells in BMDM  from 7-d-old cultures was between 5 and 
15%.  Only macrophage-like cells were found in all these colonies. Although they had 
a  shorter lag period and grew faster than  PE-CFC, it is not clear at present whether 
this class of colony-forming cell is different from PE-CFC. 
The  relationship  between  enhanced  fibrinolysis  and  proliferation  was  explored 
further with other populations of mononuclear phagocytes known to contain colony- 
forming cells (15,  19).  12% of alveolar washout cells formed colonies in liquid or agar 
culture and alveolar macrophages also expressed a  high level of fibrinolytic activity, 
thus resembling 7-d BMDM  and  l-d TPM  in both respects (Table II). A mononuclear 
cell fraction  obtained  from  blood contained  25%  of cells which  formed colonies in 
liquid culture, but no colonies were observed in agar, nor could fibrinolysis be detected 
in wells containing up  to 2  ×  t06  total  mononuclear cells. In other experiments, a 
monocyte-rich  fraction  was  obtained  by  adherence  of blood  mononuclear  cells  to 
gelatin-coated  flasks  for  3  h  and  harvest  with  15  mM  lidocaine  solution.  These 
preparations contained  -~20%  of colony-forming cells in  liquid culture,  but  showed 
very little fibrinolytic activity at 2  ×  105 cells/well. These experiments showed  that 236  PLASMINOGEN ACTIVATOR IN BONE MARROW MACROPHAGE 
a high level of fibrinolysis by a population of mononuclear phagocytes was associated 
with the presence of cells able to form colonies in agar rather than in liquid culture. 
PA Production by Individual  Colonies.  To determine what  proportion  of colonies of 
bone  marrow-derived  macrophages  contained  ceils  secreting  PA,  5  ×  104  bone 
marrow cells were grown in liquid culture in uncoated tissue culture flasks for 7 d  to 
allow formation of discrete colonies. The agarose-overlay method showed that all of 
these colonies produced  plaques of caseinolysis, which  depended  on the presence of 
ATDS for their development. We also tested PA secretion by colonies of macrophages 
derived from 7-d-old BMDM, peritoneal exudate and alveolar cells after growth in 
liquid culture for 10-14 d. Every colony present in these cultures also yielded a plaque 
of caseinolytic activity. These studies  indicated  that each colony-forming cell could 
give rise to cells that secreted PA. 
Fibrinolytic Activity of Bone Marrow Cells at Different Stages of Cultivation.  Experiments 
were designed  to study the  fibrinolytic activity of both  adherent  and  nonadherent 
cells present in the early stages of bone marrow cultures. 
Groups of gelatin-coated flasks containing 3  ×  108 bone marrow cells in  5  ml of 
growth  medium  were  incubated  at  37°C.  After  2,  24,  48,  and  72  h,  the  culture 
medium  with  nonadherent  cells  was  removed  and  saved.  The  flasks  were  washed 
twice  with  5  ml  of a-MEM  and  the  media  pooled  with  the  original  medium  to 
prepare a suspension of all nonadherent  cells. The adherent cells were then detached 
from the flasks with lidocaine solution  and washed.  The number of nucleated  cells, 
cellular morphology, the content of fast and slow growing colony-forming cells, and 
fibrinolytic activity, per cell, of both  fractions were then  determined.  Fast  growing 
colony-forming cells (CFC)  were defined as cells able to form colonies of >50 cells in 
agar within  7 d and slow growing CFC as cells which formed colonies between day 7 
and day 14. 
Although  the  results  of three  such  experiments  varied  in  detail,  the  trend  was 
similar and a representative experiment is shown in Table III. The fibrinolytic activity 
of both adherent and nonadherent ceils was low during the first 24 h  of culture and 
then increased progressively in the case of the adherent ceil fraction only. The 16-fold 
increase in fibrinolytic activity of adherent cells seen in this experiment was associated 
with a 7-fold increase in the proportion of macrophage-like cells and a  14-fold increase 
of slow growing CFC.  Fast  growing CFC varied between 0.4  and  1% of the nonad- 
herent  fraction, but were virtually absent among adherent  cells.  It should be noted 
that  nonadherent  cells contained  a  higher  fraction of polymorphonuclear cells, but 
that  all  fractions rich  in  polymorphonuclear lymphocytes had only low fibrinolytic 
activity. These studies  showed  that  active fibrinolysis and slow  growing CFC  were 
associated with the appearance of adherent  macrophages in bone marrow cultures. 
The fibrinolytic and proliferative activities of adherent cells obtained after 4-12 d 
in  culture  was  investigated  in  another series of experiments.  Cultures  containing  1 
×  106 cells in 5 ml of growth medium were fed every 4 d with 0.5 ml of fresh growth 
medium to supply nutrients.  The number of adherent  cells increased exponentially 
during the first  10 d of culture and then decreased, probably a result of overcrowding 
and detachment of cells (Fig. 2A). Very few fast growing CFC  (<0.1%)  were present 
in adherent cell fractions after the 4th d. Once again, the fibrinolytic activity per cell 
of BMDM was more closely correlated with their content of slow growing CFC  (Fig. 
2 b). The fibrinolytic activity per cell was relatively constant  between 4 and  10 d  in HSIU-SAN  LIN  AND  SAIMON  GORDON 
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Group 
CFC~/IO  4  Morphology§ (percentage of 
Time  Cell  Fibrino-  total) 
yield  Lym- 
in cul-  (×  lytic ac-  Fast  Slow  Macro-  Mature  Imma-  phocytes 
ture  10~  tivity*  grow-  grow-  phages  PMN  ture 
ing  ing  cells]l 
Nonadherent 
cells 
Adherent cells 
h 
21 
24 
48 
72 
2 
24 
48 
72 
6.7  1.3  37  22  0.2  84  5.0  11 
1.7  2.9  33  25  1.0  93  3.2  2.6 
4.7  2.7  86  47  0.5  94  3.5  2.3 
8.3  2.9  104  55  2.7  89  7.1  1.3 
2.0  3.1  1  26  14  63  17  5.2 
0.3  3.8  6  21  .... 
1.3  14  II  173  63  22  15  0 
1.5  20  4  350  93  4.0  2.9  0 
* Radioactivity released (percentage of total). After 2.5 h, each well contained 5  X  104 cells. 
:~ Fast growing CFC-formcd colonies within 7 d  and slow growing CFC-furmed colonies between days 7 
and  14. 
§ Determined by Giemsa staining of cytocentrifuge preparations. 
[[ Including all blast cells. 
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FIe.  2.  Correlation between the age of bone marrow cell cultures and the incidence of macrophage 
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TABLE IV 
Effect of Con A on Fibrinolysis by BMDM 
Con A  Fibrinolysis* 
~g/mt 
0  24.5 
0.4  29.8 
2.0  33.7 
10.0  39.5 
* Radioactivity released (percentage of total) per 5 ×  104 BMDM/2.5 h. 
culture and  then  declined  rapidly,  in  parallel  with  the proportion of slow growing 
CFC. 
Effect  of  Various Substances  on  Fibrinolysis  by  BMDM.  Con  A  has  been  shown  to 
stimulate the production and secretion of plasminogen activator in cultured peritoneal 
macrophages (23).  The effect of Con A  on the  fibrinolytic activity of BMDM  was 
therefore investigated. 
7-d BMDM were plated for 1 h on 12~I-fibrin at 5 ×  104 ceils per well. The adherent 
cells  were  washed  twice  with  serum-free  medium  and  1 ml  of Dulbecco's MEM 
containing 0.1%  lactalbumin hydrolysate added with various concentrations of Con 
A ranging from 0.4 ~g to  10 #g/ml. After 3 h of further incubation at 37°C, 50/~1 of 
ATDS were added to each well. 
As shown in Table IV, Con A enhanced the fibrinolytic activity of BMDM up to 
160% depending on the dose. 
The effect of conditioned medium from Con A-stimulated lymphoid cell cultures 
on fibrinolysis by BMDM was also studied.  The experimental  procedure was essen- 
tially the same as above except that cultures of BMDM on 125I-fibrin were exposed to 
serum-free medium conditioned by normal spleen cells or by Con A-stimulated spleen 
cells  for  24  h.  The  wells  were  then  monitored  for  release  of radioactivity  before 
washing  twice  with  prewarmed  medium  and  adding  0.5  ml  of Dulbecco's MEM 
containing 5% ATDS to each well for assay. As seen in Table V, conditioned medium 
from Con A-stimulated spleen  cells  stimulated  fibrinolysis by BMDM  up  to  240%, 
depending on  the  concentration  used.  This  enhancement  was  not  a  result  of any 
remaining Con A  itself,  because the addition of a-methyl mannoside at  the time of 
exposure  to  conditioned  medium  did  not  abolish  the  effect.  Fibrinolysis  was  not 
increased  in  BMDM  cultures  exposed  to  conditioned  medium  from  unstimulated 
spleen cells. 
We  also  tested  the effect of phagocytosis on  fibrinolytic activity of BMDM.  7-d 
BMDM were plated in 12~I-fibrin-coated  Linbro plates and exposed to  1.01-/~m latex 
particles for 30 min at 37°C. At the end of incubation, almost all BMDM contained 
>10  latex  particles  per  cell.  These  wells  were  washed  twice  to  remove  free  latex 
particles and 0.5  ml of Dulbecco's MEM  containing 5% ATDS was added  to each 
well. There was no enhancement of fibrinolytic activity after uptake of latex by these 
cells. 
Role of CSF in Regulation of Fibrinolysis by BMDM.  Because LCM was used routinely 
to generate BMDM in culture, its influence on fibrinolysis was investigated. We first 
studied  the effects of different  concentrations of LCM, varying from 0.2  to 20%  by 
volume, during the entire period of cuhure, on cell yield and fibrinolysis. The yield of HSIU-SAN LIN  AND SAIMON GORDON 
TAaLE V 
Effect of Con A-Stimulated  Spleen Cell-Conditioned Medium on Fibrinolysis by 
BMDM 
Treatment  Fibrinolysis* 
Control  17.5 
NSCM 20%  21.5 
50%  18.5 
Con A-SCM 20%  36.6 
Con A-SCM a-MM~:  35.7 
Con A-SCM 50%  41.1 
Con A-SCM a-MM:~  40.7 
* Radioactivity released (percentage of total)/5  ×  104 per cells 2.5 h. 
~: a-Methyl mannoside 0.1 M. 
TABLE VI 
Effect of Withdrawal and Addition of LCM on the Fibrinolytic Activity of BMDM* 
239 
Agar colony- 
Treatment  Cells/flask  Fibrinolysis:]:/ formin~  cells/ 
l0  s cells  10 § 
+LCM  10 ×  l0  s  28.8  88:1: 6]] 
-LCM  3 ×  105  13.8  36 ±  7 
-LCM-* +LCM  5 ×  105  50.8  86 :t:  II 
*  5-d-old bone marrow cell cultures were washed and refed with medium with or 
without LCM for 2 d, after which LCM was added to one set of cultures for a 
further day (-LCM ----} + LCM). All cells were harvested on day 8. 
~: Radioactivity released (percentage of total)/2.5 h. 
§ Colonies  counted on day 14. 
I] Mean +  SEM. 
BMDM  on  day  7  was  dependent  on  the  concentration of  LCM  and  reached  a 
maximum at  10-20%, but fibrinolytic activity per cell showed  very little difference 
among cultures. 
We next designed a  withdrawal and refeeding experiment to  explore the  role of 
LCM further. 
BMDM  which  had  been  cultured  for  5  d  in  the  presence  of complete  growth 
medium with  LCM  were washed  twice with a-MEM  to  remove nonadherent cells 
and LCM; they were then divided into three groups. To the first group, we added 4.5 
ml of complete growth  medium with  LCM,  whereas  the  second  and  third  groups 
received 4.5 ml of growth medium without LCM. After a 2-d incubation at 37°C we 
added 0.5 ml of LCM to the third group and 0.5 ml of a-MEM supplemented with 
10%  FCS to  the  first  and second groups.  After further cultivation for  1 d, the cells 
were  harvested, counted, and  assayed  for  fibrinolytic activity and  their content of 
CFC in agar. 
As shown in Table VI, the withdrawal of LCM resulted in a lower yield of adherent 
cells and a  twofold reduction in fibrinolytic activity per cell and in the incidence of 
CFC compared with cultures which had been maintained continuously  in the presence 
of LCM. This part of the experiment showed that LCM influenced PA production as 
well as the growth of BMDM and again indicated a  correlation between fibrinolytic 
activity of a cell population and its content of CFC in agar. The cultures which had 
been refed LCM 2 d after withdrawal showed some increase in cell yield and a striking 240  PLASMINOGEN ACTIVATOR IN BONE  MARROW MACROPHAGE 
TABL~ VII 
Enhancement of PA Secretion of BM'DM by CSF 
Cells  Dilution of  Source of CSF  CSF 
Colony- 
stimulating 
activity 
(colonies*/5 
×  104 BM 
cells) 
Fibrinolytic 
activity:~ 
BMDM (1  ×  105/cells) 
None 
None 
Serum-free LCM§ 
Highly purified CSF  H 
Serum-free LCM 
Highly purified CSF 
1 
¼ 
¼6 
1 
¼ 
¼6 
1 
1 
0 
172 
135 
68 
156 
142 
58 
172 
156 
7.1 
28.7 
15.7 
7.7 
25.0 
17.8 
9.6 
0.4 
0.5 
* Colonies were counted after 7 d. 
Radioactivity released (percentage of total)/2.5 h. 
§ Specific activity: 5.4 ×  l0  s colonies/mg of protein. 
[] Specific activity: 6.8 ×  10  7 colonies/mg of protein. 
fourfold increase in fibrinolytic activity per cell, higher than the cells which had been 
on LCM continuously. The proportion of agar colony-forming cells in the third and 
first  groups  were,  however,  similar.  One  possible  explanation  for  this  apparent 
dissociation  between  fibrinolytic  activity  and  the  incidence  of CFC  was  that  the 
freshly added LCM might have acted as an inducer of PA (24). 
To  investigate  whether  LCM  contained  an  inducer  of PA,  BMDM  were treated 
with LCM, directly on a25I-fibrin, for short periods before assay. 
7-d cultures of BMDM which had been starved of LCM for 2 d, were plated,  1 × 
105  per  well,  in  0.5  ml  Dulbecco's  MEM  supplemented  with  0.1%  lactalbumin 
hydrolysate.  After incubation  for 30  min  at  37°C  to allow  cells  to  adhere,  various 
amounts of test  materials or fresh medium, all serum free, were added.  The cultures 
were  incubated  for 4  more h  and  30 #1 of ATDS  then  added  to each well,  already 
containing 0.6 ml, so that the final concentration of ATDS was 5% vol/vol. Samples 
of culture  medium  were  removed  after  2.5  and  4  h  and  assayed  for  solubilized 
radioactivity. 
As shown in Table VII, the addition of serum-free LCM stimulated  fibrinolysis by 
BMDM  fourfold. Control experiments  showed that  the  LCM  itself did  not contain 
PA activity and that colony-stimulating activity was readily detectable in the LCM. 
The increased fibrinolysis in LCM-treated cultures was not a result of cell proliferation 
because the number of macrophages in treated and untreated wells did not differ over 
the  short  period  of treatment  or assay.  Increased  fibrinolysis  after  treatment  with 
LCM has been observed in >10 separate experiments using different preparations of 
LCM, although the extent of enhancement has varied between  150-400% depending, 
in  part,  on  the  basal  level  of fibrinolysis by the  BMDM  used  in  each  experiment. 
Stimulation  of fibrinolysis by LCM was dose  dependent,  could  be seen  witb  LCM 
prepared  in  the  presence  or absence  of serum  and  was  measurable  within  2  h  of 
exposure. It made no difference whether or not BMDM were starved for LCM before 
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TABLE  VIII 
Differential Enhancement by LCM* of Fibrinolysis by Various Mononuclear 
Phagocytes 
Cells 
Fibrinolysis¢ 
Control  + LCM 
RPM (t x  106 cells)  0.5  1.0 
TPM (2  ×  10  s cells)  14.2  22.4 
BMDM (2  ×  105 cells)  15.2  37.0 
* BMDM (day 7), TPM (1 d), and RPM (1 d) were harvested with lidocaine 
solution, washed, and plated on 125I-fihrin in Dulbecco's MEM with 2% FBS. 
LCM or control medium with serum was added (10%  vol/vol)  for 4  h  at 
37°C.  The  cells  were  then  washed  twice and  fibrinolysis assayed  in  5% 
ATDS. 
:~ Radioactivity released (percentage of total)/2.5 h. 
These experiments indicated that the LCM contained an inducer for fibrinolysis by 
BMDM.  Because crude serum-free LCM  contained materials  other than  CSF,  we 
used highly purified CSF from LCM to test whether CSF itself was responsible for the 
enhancement. As shown in Table VII, CSF preparations also stimulated fibrinolysis 
up to fourfold, in a dose-dependent manner, in parallel with their colony stimulating 
activity. The CSF  preparations contained no intrinsic  PA activity. This result  has 
been confirmed with three independent preparations. 
These experiments established  that  CSF  could  account  for the  enhancement  of 
fibrinolysis by LCM.  To examine the role of the BMDM  target we compared the 
effects of LCM on macrophages obtained from the peritoneal cavity and from bone 
marrow.  Table VIII shows  an  experiment  in  which  TPM  and  BMDM  displayed 
comparable  high  levels of fibrinolysis in  the  absence  of LCM.  Addition  of LCM 
further stimulated  fibrinolysis 2.5-fold  in  BMDM  and  1.5-fold  in  the  TPM.  The 
resident macrophages showed no significant fibrinolysis with or without  LCM,  We 
concluded that  LCM also enhanced fibrinolysis in targets other than BMDM,  but 
that macrophages derived from bone marrow in culture responded most readily to its 
inducing activity. 
Discussion 
These results have shown that mononuclear phagocytes derived from bone marrow 
precursor cells in culture are as active as thioglycollate medium-elicited peritoneal 
macrophages  in  producing and  secreting plasminogen activator.  BMDM  resemble 
TPM in that production of PA is unaffected by phagocytosis of latex particles (25), 
but can be enhanced by exposing them to the products of stimulated lymphoid cells 
and to Con A  (16,  23, 26). The PA activity of BMDM harvested at different times 
and after cultivation under different conditions correlates well with the incidence of 
relatively slow growing colony-forming cells (CFC). However, it is not clear at present 
whether  these  CFC  themselves  produce  PA  and  whether  the  same  cells  display 
enhanced fibrinolytic and proliferative activity. 
A close relationship between high PA production and the presence of >5% CFC is 
also  observed  with  TPM  and  alveolar  macrophages,  whereas  RPM  show  little 
fibrinolysis and contain very few CFC.  Blood monocytes, which do not secrete PA, 
form colonies in  liquid culture, but  not  in  agar  (19). These findings indicate that 242  PLASMINOGEN ACTIVATOR IN BONE MARROW MACROPHAGE 
proliferation in agar may be more closely related to production of PA by a population 
of mononuclear phagocytes. Our results resemble previous reports linking PA produc- 
tion to the formation of colonies in agar by virus transformed fibroblasts.  Primary 
cultures of normal embryo fibroblasts which proliferate in liquid culture and not in 
agar may secrete little PA, but acquire the ability to grow in agar and produce high 
levels of PA after transformation (27,  28). 
One explanation  for the  high  fibrinolytic activity of 5-10  d  BMDM  is  that  the 
LCM required for growth also contains a  substance which enhances PA. It is likely 
that  CSF  stimulates  both  proliferation  and  PA  in  this  system  because  these  two 
activities cofractionate during extensive purification. Further studies should establish 
whether both activities are indeed mediated by the same molecule. 
The physiologic role of CSF is not known at present, but it is required not only for 
the proliferation of CFU-C and other colony-forming cells related to the mononuclear 
phagocyte system, but also for the survival and maturation of these cells in vitro (18, 
29, 30). The enhancement of fibrinolysis in BMDM by LCM and CSF was rapid and 
still detectable after 1 d of continuous exposure. Withdrawal experiments showed that 
the effect on proliferation and fibrinolysis was reversible. CSF, therefore, provides a 
unique mechanism to regulate the number as well as the specific fibrinolytic activity 
of mononuclear phagocytes.  Different sources of mononuclear phagocytes  vary in 
their response to CSF, but the number of target cells involved in each cell population 
and the mechanism of action of CSF remain to be determined. 
The presence of CSF-like substances has been documented in inflammatory exu- 
dates  (31-33).  Fibroblasts  in  peritoneal  exudate  cultures  produce  CSF  (34)  and 
mononuclear phagocytes themselves may release CSF when appropriately stimulated 
(35-37). Production of CSF by other cells provides another pathway for inducing PA 
in  macrophages  which  accumulate  at  a  site  of inflammation,  analogous  to  the 
production of a lymphokine inducer of PA by T  lymphocytes after immune stimula- 
tion and challenge (26). We have been unable to detect colony-stimulating activity in 
supernates of lymphoid cells containing high levels of PA inducing activity after Con 
A  or  BCG stimulation  (H.-S.  Lin  and  S.  Gordon, unpublished  observations), but 
further studies  are needed to determine whether CSF and  lymphokine are distinct 
inducers of PA. 
The present studies add to our knowledge of the sequence of appearance of marker 
products as macrophages proliferate and differentiate in culture. High levels of PA 
production were found in cultures rich in adherent macrophages which also produce 
lysozyme and  express  receptors  for  Fc  and  C3,  as  described  by  others  (38-40). 
Improved single cell methods will be needed to detect and identify cells which may 
produce PA during earlier stages of differentiation. The decline of PA observed in 
older bone marrow cultures may represent macrophage maturation, but could also be 
due to unfavorable conditions after prolonged cultivation.  The generation of high 
levels of plasmin by BMDM could itself influence the differentiation process observed 
in culture (41, 42). 
Our studies on  PA regulation in BMDM  underline the importance of the devel- 
opmental history and the role of newly divided cells in macrophage activation (43- 
45). In addition to secreting PA, BMDM produce and release other neutral proteinases 
in culture (46) and can be stimulated by lymphokines to display enhanced cytocidal 
activity  and  inhibition  of migration  (8,  9).  BMDM  can  therefore be  regarded  as HSIU-SAN LIN AND SAIMON GORDON  243 
partially activated cells which  are highly responsive to CSF and lymphokines com- 
pared  with  resident  macrophages.  The  production  of PA  by  BMDM  provides  a 
sensitive method to study the role of CSF and its interaction with cellular targets in 
macrophage activation. 
Summary 
We have studied  the  production  of plasminogen activator (PA)  by mononuclear 
phagocytes  derived  from  mouse  bone  marrow precursor  cells  (CFU-C)  in  culture. 
Bone  marrow-derived macrophages  (BMDM)  obtained after 6-8-d cultivation  in  a 
liquid  medium  containing  L-cell-conditioned  medium  (LCM),  a  source  of colony 
stimulating factor (CSF), showed a  high level of fibrinolytic activity comparable to 
that of thioglycollate medium-induced  peritoneal macrophages (TPM)  and at  least 
20-fold higher than that of resident peritoneal macrophages (RPM). Fibrinolysis was 
a result of active secretion of PA into the culture medium and plaques of caseinolysis 
could  be  detected  by an  overlay  assay over all  macrophage colonies  formed  after 
cloning of bone marrow cells in culture. 
When  the fibrinolytic activity of BMDM harvested at different times was investi- 
gated,  it  was  found  that  the  level  of PA  activity  of a  given  BMDM  population 
correlated  well  with  the  incidence  of cells  (5-15%)  able  to  proliferate  and  form 
colonies in agar after 7-14 d, somewhat more slowly than  CFU-C. This correlation 
between the level of PA secretion and the incidence of agar colony-forming cells was 
also  found with other mononuclear  phagocyte populations.  Active fibrinolysis and 
slow  growing  colony-forming  cells  were  observed  at  the  same  time  as  adherent 
macrophages appeared, 2-3 d  after the start of bone marrow culture,  they persisted 
for 10 d  before declining. 
Some of the factors which  influenced  PA production by BMDM were examined. 
Fibrinolysis  could  be  enhanced  two-  to  fourfold  by  exposing  the  cells  for  4  h  to 
concanavalin A  (Con  A), to medium conditioned  by Con A-stimulated spleen cells 
and to LCM, but not by phagocytosis of latex particles. The substance in LCM that 
stimulated PA production appeared to be identical to CSF. Mononuclear phagocyte 
targets  differed  in  their  response  to  LCM,  which  stimulated  fibrinolysis readily  in 
BMDM, to a lesser extent in TPM and not at all in RPM. 
We conclude  that  CSF  stimulates  both  proliferation  and  fibrinolytic activity  in 
BMDM  and that  the level of macrophage activation, as defined by PA production, 
can  be further  enhanced  by lymphokines.  Induction  of PA  in  BMDM  provides  a 
rapid and sensitive assay for measuring the activity of CSF and defining its role in 
macrophage activation. 
We thank Julie Cordell and Pat Clarke for excellent  technical help. 
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